A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis

New England Journal of Medicine

Volumn 326, Issue 9, 1992, Pages 581-588

  Beck, Roy W ^a   Cleary, Patricia A ^b   Anderson, Malcolm M ⁱ   Keltner, John L ^c   Shults, William T ^t   Kaufman, David I ^r   Buckley, Edward G ⁱ   Corbett, James J ⁿ   Kupersmith, Mark J ^s   Miller, Neil R ^p   Savino, Peter J ^o   Guy, John R ^k   Trobe, Jonathan D ^q   McCrary, John A ^g   Smith, Craig H ^u   Chrousos, Georgia A ^l   Thompson, H Stanley ⁿ   Katz, Barrett J ^h   Brodsky, Michael C ^f   Goodwin, James A ^m   Atwell, Constance W ^e   Sellers, B J ^a   Backlund, J C ^b   Kenny, D ^b   Loring, N ^b   Campbell, S ^b   Gilbert, P ^b   Watson, W ^b   Zablotny, J ^b   Johnson, C ^c   Spurr, J ^c   Shapiro, L ^c   Murtagh, R ^d   Arrington, J ^d   Lyon, B ^f   Nazarian, S ^f   Jay, W ^f   Luther, A ^f   Ford, R ^f   Slight, B ^g   Gross, R ^g   Rolak, L ^g   Frady, P ^g   Hawker, N ^h   Paul, O ^h   Swenson, M ^h   Loey, N ^h   Kelly, N ^h   Valentine, G ⁱ   Pollock, S ⁱ   Massey, W ⁱ   Duncan, L ⁱ   Kossover, K ⁱ   Griffin, L ⁱ   Grimson, B ^j   Tripoli, N ^j   Messenheimer, J ^j   Fletcher, D ^j   Shamis, D ^k   Zam, S ^k   Hamed, L ^k   Malone, J ^k   Willingham, M ^k   Lauber, S ^l   Kattah, J ^l   Coyle, E ^l   Sullivan, E ^m   Winterbotham, C ^m   Nichols, J ^m   Skorin, L ^m   Bobak, P ^m   Putz, J ^m   Musser, C ⁿ   Kardon, R ⁿ   Johnston, P ⁿ   Mitchell, G ⁿ   Delsing, J ⁿ   Fountain, C ⁿ   Devlin, M ^o   Sergott, R ^o   Bosley, T ^o   Cantor, C ^o   Santa Maria, K ^o   Ward, S ^o   Krich Putzulo, C ^p   Repka, M ^p   Buchholz, D ^p   Reich, S ^p   West, L ^p   Caudill, C ^q   Cornblath, W ^q   Kruscke, L ^q   Michael, B ^q   Froehlich, J ^r   Moore, T ^r   Ristow, G ^r   Zendler, B ^r   Kokinakis, J ^r   Rosick, E ^r   Barris, M ^r   Addessi, A ^s   Warren, F ^s   Wahba, S ^s   Diehl, L ^t   Dreyer, R ^t   Zilis, J ^t   Wilson, R ^t   Herndon, R ^t   Gibbs, D ^t   Leonard, H ^t   Beardsley, C ^t   Arends, J ^t   Steffen, K ^t   Royce, B ^t   McKenna, D ^t   Ernst, P ^u   Orcutt, J ^u   Mills, R ^u   Longstreth, W ^u   Smith, S ^u   Lawrence, B ^u   Bjorn, D ^u   Cady, Y ^u   Fisher, M ^v   Alguire, P ^v   Carl, J ^v   Rubin, G ^v   Weinstein, J ^v   Smith, V ^v   Dunbar Jacob, J ^v   more..

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d University Diagnostic Institute   (United States)

^e NATIONAL EYE INSTITUTE   (United States)

^f UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^g CULLEN EYE INSTITUTE   (United States)

^h Smith—Kettlewell Eye Research Institute ^*  (United States)

ⁱ DUKE UNIVERSITY   (United States)

^j UNIVERSITY OF NORTH CAROLINA   (United States)

^k UNIVERSITY OF FLORIDA   (United States)

^l GEORGETOWN UNIVERSITY   (United States)

^m UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

ⁿ UNIVERSITY OF IOWA   (United States)

^o THOMAS JEFFERSON UNIVERSITY   (United States)

^p JOHNS HOPKINS UNIVERSITY   (United States)

^q UNIVERSITY OF MICHIGAN   (United States)

^r MICHIGAN STATE UNIVERSITY   (United States)

^s NEW YORK UNIVERSITY   (United States)

^t DEVERS EYE INSTITUTE   (United States)

^u UNIVERSITY OF WASHINGTON   (United States)

^v NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; PLACEBO; PREDNISONE;

ADULT; ARTICLE; CLINICAL TRIAL; COLOR VISION; CONTRAST SENSITIVITY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; OPTIC NERVE DISEASE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK; VISION; VISUAL ACUITY; VISUAL FIELD;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; COLOR PERCEPTION; COMPARATIVE STUDY; FEMALE; FOLLOW-UP STUDIES; HUMAN; INJECTIONS, INTRAVENOUS; MALE; METHYLPREDNISOLONE; MIDDLE AGE; MULTIPLE SCLEROSIS; OPTIC NEURITIS; PATIENT COMPLIANCE; PREDNISONE; RECURRENCE; SUPPORT, U.S. GOV'T, P.H.S.; VISUAL ACUITY; VISUAL FIELDS;

EID: 0026586019     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199202273260901     Document Type: Article

References (23)

1. Ebers G.C. Optic neuritis and multiple sclerosis. Arch Neurol 1985; 42:702-704
2. Fleishman J.A., Beck R.W., Linares O.A., Klein J.W. Deficits in visual function after resolution of optic neuritis. Ophthalmology 1987; 94:1029-1035
3. Sanders E.A.C.M., Volkers A.C.W., van der Poel J.C., van Lith G.H.M. Estimation of visual function after optic neuritis: a comparison of clinical tests. Br J Ophthalmol 1986; 70:918-924
4. Rawson M.D., Liversedge L.A., Goldfarb G. Treatment of acute retrobulbar neuritis with corticotrophin. Lancet 1966; 2:1044-1046
5. Rawson M.D., Liversedge L.A. Treatment of retrobulbar neuritis with corticotrophin. Lancet 1969; 2:222.
6. Gould E.S., Bird A.C., Leaver P.K., McDonald W.I. Treatment of optic neuritis by retrobulbar injection of triamcinolone. BMJ 1977; 1:1495-1497
7. Rose A.S., Kuzma J.W., Kurtzke J.F., Namerow N.S., Sibley W.A., Tourtellotte W.W. Cooperative study in the evaluation of therapy in multiple sclerosis: ACTH vs. placebo — final report. Neurology 1970; 20:1-59.
8. Bowden A.N., Bowden P.M.A., Friedmann A.I., Perkin G.D., Rose F.C. A trial of corticotrophin gelatin injection in acute optic neuritis. J Neurol Neurosurg Psychiatry 1974; 37:869-873
9. Spoor T.C., Rockwell D.L. Treatment of optic neuritis with intravenous megadose corticosteroids: a consecutive series. Ophthalmology 1988; 95:131-134
10. Optic Neuritis Study Group. The clinical profile of optic neuritis: experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol 1991; 109:1673-1678
11. Optic Neuritis Treatment Trial manual of procedures. Springfield, Va.: National Technical Information Service, 1990. (NTIS accession no. PB90–195728.)
12. Poser C.M., Paty D.W., Scheinberg L., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
13. Wilcoxon F. Individual comparison by ranking methods. Biometrics 1945; 1:80-83
14. Wei L.J., Lachin J.M. Two-sample asymptotically distribution-free tests for incomplete multivariate observations. J Am Stat Assoc 1984; 79:653-661
15. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22:719-748
16. Breslow N.E. A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship. Biometrika 1970; 57:579-594
17. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-481
18. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50:163-170
19. Herishanu Y.O., Badarna S., Sarov B., Abarbanel J.M., Segal S., Bearman J.E. A possible harmful late effect of methylprednisolone therapy on a time cluster of optic neuritis. Acta Neurol Scand 1989; 80:569-574
20. Bracken M.B., Shepard M.J., Collins W.F., et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury: results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990; 322:1405-1411
21. Goodin D.S. The use of immunosuppressive agents in the treatment of multiple sclerosis: a critical review. Neurology 1991; 41:980-985
22. Visual signs at presentation. In: Perkin GD, Rose FC. Optic neuritis and its differential diagnosis. Oxford, England: Oxford University Press, 1979: 43-73.
23. Nikoskelainen E. Symptoms, signs and early course of optic neuritis. Acta Ophthalmol (Copenh) 1975; 53:254-272